Israel
· Delayed Price · Currency is ILS · Price in ILA OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of ILS 3.57 billion. The enterprise value is 3.80 billion.
| Market Cap | 3.57B |
| Enterprise Value | 3.80B |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 793.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -7.48% |
| Shares Change (QoQ) | -29.44% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 375.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 13.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -26.16 |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.95 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.38.
| Current Ratio | 2.49 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.39 |
| Interest Coverage | -4.87 |
Financial Efficiency
Return on equity (ROE) is -3.04% and return on invested capital (ROIC) is -9.68%.
| Return on Equity (ROE) | -3.04% |
| Return on Assets (ROA) | -8.20% |
| Return on Invested Capital (ROIC) | -9.68% |
| Return on Capital Employed (ROCE) | -14.69% |
| Revenue Per Employee | 856,527 |
| Profits Per Employee | -48,455 |
| Employee Count | 2,997 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 9.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.42% in the last 52 weeks. The beta is 1.42, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -3.42% |
| 50-Day Moving Average | 581.21 |
| 200-Day Moving Average | 572.72 |
| Relative Strength Index (RSI) | 25.23 |
| Average Volume (20 Days) | 809,054 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.73 |
Income Statement
In the last 12 months, OPKO Health had revenue of ILS 2.57 billion and -145.22 million in losses. Loss per share was -0.21.
| Revenue | 2.57B |
| Gross Profit | 390.76M |
| Operating Income | -1.00B |
| Pretax Income | -2.15M |
| Net Income | -145.22M |
| EBITDA | -645.70M |
| EBIT | -1.00B |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 1.60 billion in cash and 1.84 billion in debt, giving a net cash position of -238.52 million.
| Cash & Cash Equivalents | 1.60B |
| Total Debt | 1.84B |
| Net Cash | -238.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.88B |
| Book Value Per Share | 7.27 |
| Working Capital | 1.64B |
Cash Flow
In the last 12 months, operating cash flow was -679.45 million and capital expenditures -88.47 million, giving a free cash flow of -767.93 million.
| Operating Cash Flow | -679.45M |
| Capital Expenditures | -88.47M |
| Free Cash Flow | -767.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 15.22%, with operating and profit margins of -39.06% and -5.66%.
| Gross Margin | 15.22% |
| Operating Margin | -39.06% |
| Pretax Margin | -0.08% |
| Profit Margin | -5.66% |
| EBITDA Margin | -25.15% |
| EBIT Margin | -39.06% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.48% |
| Shareholder Yield | 7.48% |
| Earnings Yield | -4.07% |
| FCF Yield | -21.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.5 |
| Piotroski F-Score | n/a |